Granite Harbor Advisors’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
AIM
FWIA
Granite Harbor Advisors's BMY Position: Q2 2026 in Review
Granite Harbor Advisors increased its Bristol-Myers Squibb (BMY) stake by 5.9% in Q2 2026, buying an estimated $12.5K and bringing the position to 3,887 shares worth $224K. The position accounts for 0.09% of the portfolio, ranked #122.
Granite Harbor Advisors first reported a position in BMY in Q1 2026 and has held it in 2 quarters since. 1,158 funds tracked by Wall St. Rank hold BMY as of Q2 2026.
- Granite Harbor Advisors held 3,887 shares of Bristol-Myers Squibb worth $224K as of Q2 2026.
- Granite Harbor Advisors bought 217 Bristol-Myers Squibb shares in Q2 2026, an estimated $12.5K.
- Bristol-Myers Squibb made up 0.09% of Granite Harbor Advisors's portfolio in Q2 2026, its #122 holding.
- Granite Harbor Advisors first reported a position in Bristol-Myers Squibb in Q1 2026 and has held it in 2 quarters since.
- 1,158 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.
Based on Granite Harbor Advisors's 13F filing for Q2 2026, filed 31 Jul 2026.